Global Mice Model Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.2.1 Secondary Research
1.2.2 Primary Research
1.3 Market Segmentation
1.4 Assumptions and Stipulations

Chapter 2 Executive Summary
2.1 Global Mice Consumption, 2016
2.2 Market Snapshot: Global Mice Model Market (2018 and 2026E)
2.3 Global Mice Model Market, by Type, 2018 (USD Million)
2.4 Global Mice Model Market, by Application, 2018 (USD Million)
2.5 Global Mice Model Market, by Services, 2018 (USD Million)
2.6 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2018 and 2026E (Value %)

Chapter 3 Global Mice Model Market: Market Overview
3.1 Overview
3.1.1 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
3.2 End-users of Mice Models
3.2.1 End-user Analysis of Mice Model Market (Value %), 2016
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Growing investment in biomedical research
3.3.1.2 Biomedical Research Growth Rate, 2007–2012, (%)
3.3.1.3 Growing number of advanced mice model would increase applicability and acceptability
3.3.1.4 Personalized in vivo analysis mice models would fuel demand for mice models in personalized medicine
3.3.2 Restraints
3.3.2.1 Rising concern about animal use across the globe would restrain the market
3.3.2.2 Development of alternative technologies
3.3.3 Opportunities
3.3.3.1 Countries in Asia offer immense growth opportunities in the mice model market
3.4 Event Impact Assessment: Mice Model Market
3.5 Market Attractiveness Analysis: Global Mice Model Market
3.5.1 Mice Model Market Analysis: The U.S. and China
3.5.2 Market Attractiveness Analysis: Global Mice Model Market, by Geography
3.5.3 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
3.6 Competitive Landscape
3.6.1 Global Market Share Analysis, by Key Players, 2016 (Value %)
3.6.2 Global Market Share Analysis, by Key Players, 2018 (Value %)
3.6.3 Heat Map Analysis, by Key Geography, 2018 (Market Share)
3.6.4 Heat Map Analysis, by Key Geography, 2018 (Market Growth)

Chapter 4 Global Mice Model Market, by Type
4.1 Overview
4.1.1 Global Mice Model Market, by Type, 2016–2018 (USD Million)
4.1.2 Global Mice Model Market, by Model Type, 2019E–2026E (USD Million)
4.2 Transgenic Mice Model
4.2.1 Transgenic Mice Applications in Various Specialties (%)
4.2.2 Global Transgenic Mice Model Market, 2016–2026E (USD Million)
4.3 Hybrid/Congenic Mice Model
4.3.1 Global Hybrid/Congenic Mice Model Market, 2016–2026E (USD Million)
4.4 Knockout Mice Model
4.4.1 Knockout Mice Applications in Various Specialties, 2018 (%)
4.4.2 Global Knockout Mice Model Market, 2016–2026E (USD Million)
4.5 Carcinogen-induced and Spontaneous Mice Model
4.5.1 Global Carcinogen-induced and Spontaneous Mice Model Market, 2016–2026E (USD Million)
4.6 Outbred Mice Model
4.6.1 Global Outbred Mice Model Market, 2016–2026E (USD Million)
4.7 Inbred Mice Model
4.7.1.1 Inbred Mice Applications in various Specialties (%), 2018
4.7.1.2 Global Inbred Mice Model Market, 2016–2026E (USD Million)
4.8 Transplantation Mice Model
4.8.1 Global Transplantation Mice Model Market, 2016–2026E (USD Million)
4.9 Conditioned/Surgically Modified Mice Model
4.9.1 Global Conditioned/Surgically Modified Mice Model Market, 2016–2026E (USD Million)

Chapter 5 Global Mice Model Market, by Specialty
5.1 Overview
5.1.1 Global Mice Model Market, by Application, 2016–2018 (USD Million)
5.1.2 Global Mice Model Market, by Application, 2019E–2026E (USD Million)
5.2 Immunology
5.2.1 Global Immunology Mice Model Market, 2016–2026E (USD Million)
5.2.2 Number of Immunology Mice Models, by Major Companies
5.2.3 Immunology Mice Model Market Share, by Model Type, 2018
5.3 Central Nervous System (CNS)
5.3.1 Global CNS Mice Model Market, 2016–2026E (USD Million)
5.3.2 Number of CNS Mice Models, by Major Companies
5.3.3 CNS Mice Model Market Share, by Model Type, 2018
5.4 Oncology
5.4.1 Global Oncology Mice Model Market, 2016–2026E (USD Million)
5.4.2 Number of Oncology Mice Models, by Major Companies
5.4.3 Oncology Mice Model Market Share, by Model Type, 2018
5.5 Cardiovascular
5.5.1 Global Cardiovascular Mice Model Market, 2016–2026E (USD Million)
5.5.2 Number of Cardiovascular Mice Models, by Major Companies
5.5.3 Cardiovascular Mice Model Market Share, by Model Type, 2018
5.6 Diabetes
5.6.1 Global Diabetes Mice Model Market, 2016–2026E (USD Million)
5.6.2 Number of Diabetes Mice Models, by Major Companies
5.6.3 Diabetes Mice Model Market Share, by Model Type, 2018
5.7 Metabolism & Regulation
5.7.1 Global Metabolism & Regulation Mice Model Market, 2016–2026E (USD Million)
5.7.2 Metabolism & Regulation Mice Models Market Share, by Model Type, 2018

Chapter 6 Global Mice Model Market, by Services
6.1 Overview
6.1.1 Global Mice Model Market, by Services, 2016–2018 (USD Million)
6.1.2 Global Mice Model Market, by Services, 2019E–2026E (USD Million)
6.2 Breeding and Rederivation Services
6.2.1 Global Breeding and Rederivation Services Market, 2016–2026E (USD Million)
6.3 Cryopreservation and Cryorecovery Services
6.3.1 Global Cryopreservation and Cryorecovery Services Market, 2016–2026E (USD Million)
6.4 Quarantine Services
6.4.1 Global Quarantine Services Market, 2016–2026E (USD Million)
6.5 Genetic Testing Services
6.5.1 Global Genetic Testing Services Market, 2016–2026E (USD Million)
6.6 Model In-licensing Services
6.6.1 Global Model In-licensing Market, 2016–2026E (USD Million)
6.7 In vivo and In vitro Pharmacology Services
6.7.1 Global In vivo and In vitro Pharmacology Services Market, 2016–2026E (USD Million)
6.8 Genetically Engineered Model Services
6.8.1 Genetically Engineered Model Services
6.9 Other Services (Surgical and Line Rescue)
6.9.1 Global Other Services Market, 2016–2026E (USD Million)

Chapter 7 Global Mice Model Market, by Geography
7.1 Overview
7.1.1 Mice Model Market Share Index, 2018 (On Scale of 1 to 5)
7.1.2 Global Mice Model Market, Growth Index, 2019–2026 (On a Scale of 1 to 5)
7.1.3 Global Mice Model Market Revenue, by Geography, 2016–2026 (USD Million)
7.2 North America
7.2.1 North America Population, GDP, and Health care Expenditure, 2011–2016
7.2.2 North America Mice Model Market Revenue, 2016–2026E (USD Million
7.2.3 U.S.
7.2.3.1 U.S. Mice Model Market, 2016–2026E (USD Million)
7.2.4 Canada
7.2.4.1 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
7.2.4.2 Canada Mice Model Market, 2016–2026E (USD Million)
7.3 Europe
7.3.1 Europe Population, GDP, and Health care Expenditure, 2011–2016
7.3.2 Europe Mice Model Market Revenue, 2016–2026E (USD Million)
7.3.3 Germany
7.3.3.1 Germany Mice Model Market Revenue, 2016–2026E (USD Million)
7.3.4 U.K.
7.3.4.1 U.K. Mice Model Market Revenue, 2016–2026E (USD Million)
7.3.5 Rest of Europe
7.3.5.1 Rest of Europe Mice Model Market Revenue, 2016–2026E (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2016
7.4.2 Asia Pacific Mice Model Market Revenue, 2016–2026E (USD Million)
7.4.3 Japan
7.4.3.1 Japan Mice Model Market, 2016–2026E (USD Million)
7.4.4 China
7.4.4.1 China Mice Model Market, 2016–2026E (USD Million)
7.4.5 Rest of Asia Pacific
7.4.5.1 Rest of Asia Pacific Mice Model Market, 2016–2026E (USD Million)
7.5 Latin America
7.5.1 Latin America Population, GDP, and Health care Expenditure, 2011 – 2016
7.5.2 Latin America Mice Model Market, 2016–2026E (USD Million)
7.5.3 Brazil
7.5.3.1 Brazil Mice Model Market, 2016–2026E (USD Million)
7.5.4 Mexico
7.5.4.1 Mexico Mice Model Market, 2016–2026E (USD Million)
7.5.5 Rest of Latin America
7.5.5.1 Rest of Latin America Mice Model Market, 2016–2026E (USD Million)
7.6 Middle East & North Africa (MENA)
7.6.1 MENA Mice Model Market, 2016–2026E (USD Million)
7.6.2 Saudi Arabia (KSA)
7.6.2.1 Saudi Arabia Mice Model Market, 2016–2026E (USD Million)
7.6.3 UAE
7.6.3.1 UAE Mice Model Market, 2016–2026E (USD Million)
7.6.4 Israel
7.6.4.1 Israel Mice Model Market, 2016–2026E (USD Million)
7.6.5 Rest of MENA
7.6.5.1 Rest of MENA Mice Model Market, 2016–2026E (USD Million)
7.7 Rest of the World (RoW)
7.7.1 RoW Population, GDP, and Health care Expenditure, 2011–2016
7.7.2 Rest of World Mice Model Market, 2016–2026E (USD Million)

Chapter 8 Recommendations
8.1 Focus on collaborations with contract research organizations or strengthening in-house research capabilities
8.2 Sustaining pricing pressures in a declining global economic scenario
8.3 Investing in emerging markets such as India, China, and Brazil

Chapter 9 Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Crescendo Biologics Limited
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Deltagen, Inc.
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 genOway S.A.
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Harbour Antibodies BV
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Harlan Laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 ImmunoGenes AG
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 SAGE Labs
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 The Jackson Laboratory
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Taconic Biosciences, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 TransGenic, Inc.
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments

Report Details

  • Report Code:28876
  • Category:Healthcare
  • No. of Pages:140
  • Format:PDF/PPT/Excel
  • Published:August 2019
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers